Abstract:High-throughput screening (HTS), as one of the key techniques in drug discovery, is frequently used to identify promising drug candidates in a largely automated and cost-effective way. One of the necessary conditions for successful HTS campaigns is a large and diverse compound library, enabling hundreds of thousands of activity measurements per project. Such collections of data hold great promise for computational and experimental drug discovery efforts, especially when leveraged in combination with modern deep learning techniques, and can potentially lead to improved drug activity predictions and cheaper and more effective experimental design. However, existing collections of machine-learning-ready public datasets do not exploit the multiple data modalities present in real-world HTS projects. Thus, the largest fraction of experimental measurements, corresponding to hundreds of thousands of "noisy" activity values from primary screening, are effectively ignored in the majority of machine learning models of HTS data. To address these limitations, we introduce Multifidelity PubChem BioAssay (MF-PCBA), a curated collection of 60 datasets that includes two data modalities for each dataset, corresponding to primary and confirmatory screening, an aspect that we call <i>multifidelity</i>. Multifidelity data accurately reflect real-world HTS conventions and present a new, challenging task for machine learning: the integration of low- and high-fidelity measurements through molecular representation learning, taking into account the orders-of-magnitude difference in size between the primary and confirmatory screens. Here we detail the steps taken to assemble MF-PCBA in terms of data acquisition from PubChem and the filtering steps required to curate the raw data. We also provide an evaluation of a recent deep-learning-based method for multifidelity integration across the introduced datasets, demonstrating the benefit of leveraging all HTS modalities, and a discussion in terms of the roughness of the molecular activity landscape. In total, MF-PCBA contains over 16.6 million unique molecule-protein interactions. The datasets can be easily assembled by using the source code available at https://github.com/davidbuterez/mf-pcba.

Deconvoluting Low Yield from Weak Potency in Direct-to-Biology Workflows with Machine Learning

Deconvoluting Low Yield from Weak Potency in Direct-to-Biology Workflows with Machine Learning

Ultrahigh-Throughput Enzyme Engineering and Discovery in In Vitro Compartments

NanoStore: A Concept for Logistical Improvements of Compound Handling in High-Throughput Screening

Machine Learning-Driven Data Valuation for Optimizing High-Throughput Screening Pipelines

De Novo Generation and Identification of Novel Compounds with Drug Efficacy Based on Machine Learning

High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery

Data Valuation: A novel approach for analyzing high throughput screen data using machine learning

Dynamic Compound-Dependent Acoustic Transfer to Investigate Inhibitor Reversibility

Digital Microfluidics for Sample Preparation in Low‐Input Proteomics

Parallel Purification of Microscale Libraries via Automated Solid Phase Extraction

Role of Digital Microfluidics in Enabling Access to Laboratory Automation and Making Biology Programmable

Machine Learning Assisted Hit Prioritization for High Throughput Screening in Drug Discovery

Optimisation of surfactin yield in using active learning and high-throughput mass spectrometry

MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning

Multiplexed and reproducible high content screening of live and fixed cells using Dye Drop

Optimization of a deep mutational scanning workflow to improve quantification of mutation effects on protein–protein interactions

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

Low-N protein engineering with data-efficient deep learning

Combating small molecule aggregation with machine learning